Literature DB >> 2025254

12-Hydroxyeicosatetraenoic acid (12-HETE) induces heat shock proteins in human leukocytes.

M Köller1, W König.   

Abstract

12-Hydroxyeicosatetraenoic acid (12-HETE) induces the expression of individual heat shock proteins in human leukocytes (lymphocytes, monocytes, basophil granulocytes; LMBs). Metabolic radiolabeling of LMBs revealed that exogenous 12-HETE (20 ng) led to the expression of a 65- and 83kDa protein. Immunoreactivity towards the 65kDa protein was commonly detected. In contrast, after heat shock treatment and predominantly after incubation with 12-HETE significant immunoreactivity (anti-hsp72) was detected in the lower molecular weight range whereas immunoreactivity (anti-hsp90, AC88) was only observed after heat shock treatment of LMBs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2025254     DOI: 10.1016/0006-291x(91)91636-q

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Induction of inflammatory mediator release (serotonin and 12-hydroxyeicosatetraenoic acid) from human platelets by Pseudomonas aeruginosa glycolipid.

Authors:  B König; U Bergmann; W König
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

2.  The role of the phosphatidylinositol turnover in 12-hydroxyeicosatetraenoic acid generation from human platelets by Escherichia coli alpha-haemolysin, thrombin and fluoride.

Authors:  B König; W König
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

3.  Regulation of heat shock protein synthesis by quercetin in human erythroleukaemia cells.

Authors:  G Elia; M G Santoro
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

4.  Protection from tumor necrosis factor-mediated cytolysis by platelets.

Authors:  C Philippe; B Philippe; B Fouqueray; J Perez; M Lebret; L Baud
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

Review 5.  Membranes: a meeting point for lipids, proteins and therapies.

Authors:  Pablo V Escribá; José M González-Ros; Félix M Goñi; Paavo K J Kinnunen; Lászlo Vigh; Lissete Sánchez-Magraner; Asia M Fernández; Xavier Busquets; Ibolya Horváth; Gwendolyn Barceló-Coblijn
Journal:  J Cell Mol Med       Date:  2008-02-08       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.